FDA Declines Rilonacept for Gout Flares
06:33 EDT 31 Jul 2012 | Medscape
The FDA has sent Regeneron a complete response letter requesting more data regarding the use of rilonacept for this indication. Medscape Medical News
Original Article: FDA Declines Rilonacept for Gout Flares
More From BioPortfolio on "FDA Declines Rilonacept for Gout Flares"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
